aid: elixiron-immunotherapeutics
name: Elixiron Immunotherapeutics
description: 'Elixiron Immunotherapeutics (Cayman) Limited is a clinical-stage biopharmaceutical
  company founded in 2017, with offices in Taipei, Taiwan and Cambridge, Massachusetts,
  developing precision immunotherapies for neuroinflammation, autoimmune disease and
  cancer. Its clinical pipeline is led by enrupatinib (EI-1071), a small-molecule CSF-1R
  inhibitor in development for Alzheimer''s disease and other neurodegenerative indications,
  and EI-001, a fully human anti-interferon-gamma monoclonal antibody in Phase 2 for
  vitiligo, alongside preclinical EI-012 (anti-CD36) and EI-220 (mRNA) oncology programs.
  The company publishes a corporate and investor-relations website only: there is no
  developer portal, public API, SDK, webhook surface or machine-readable specification
  of any kind on its own hosts.'
url: https://raw.githubusercontent.com/api-evangelist/elixiron-immunotherapeutics/refs/heads/main/apis.yml
image: https://elixiron.com/dist/images/common/og.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immunotherapy
- Life Sciences
- Clinical Trials
- Healthcare
- Taiwan
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/elixiron-immunotherapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/elixiron-immunotherapeutics-llms.txt
- type: Website
  url: https://elixiron.com/
- type: About
  url: https://elixiron.com/about.php
- type: Contact
  url: https://elixiron.com/contact.php
- type: News
  url: https://elixiron.com/news.php
- type: LinkedIn
  url: https://www.linkedin.com/company/elixiron-immunotherapeutics
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Elixiron Immunotherapeutics is a clinical-stage biopharmaceutical company whose only
    production host, elixiron.com, serves a PHP corporate and investor-relations site whose
    57-URL sitemap contains no developer, API or documentation page at all.
  evidence:
  - url: https://elixiron.com/sitemap.xml
    status: 200
  - url: https://elixiron.com/openapi.json
    status: 404
  - url: https://elixiron.com/.well-known/agent-card.json
    status: 404
  - url: https://elixiron.com/llms.txt
    status: 404
  checked: '2026-08-12'